MannKind | MNKD - Текущие обязательства





Текущие обязательства Изменить Дата
Adma Biologics USD 73.54M 4M 2026-03
BioCryst Pharmaceuticals USD 195.39M 675K 2026-03
Eli Lilly USD 36.63B 1.41B 2026-03
Halozyme Therapeutics USD 363.21M 186.12M 2026-03
Insmed USD 361.01M 107.87M 2026-03
Karyopharm Therapeutics USD 92.06M 4.9M 2025-12
MacroGenics USD 95.94M 52.82M 2026-03
MannKind USD 134.56M 36.47M 2026-03
Merck USD 26.94B 1.38B 2026-03
Minerva Neurosciences USD 2.29M 381K 2025-12
Novavax USD 342.46M 117.49M 2026-03
Novo Nordisk DKK 32.79B 203.33B 2025-06
Pfizer USD 34.35B 2.64B 2026-03
Sanofi EUR 30.01B 1.66B 2026-03
Xencor USD 73.46M 22.45M 2026-03